Reported Q: Q1 2026 Rev YoY: N/A EPS YoY: +100.9% Move: +5.00%
Cannabis Suisse Corp
CSUI
$0.00630 5.00%
Exchange OTC Sector Healthcare Industry Drug Manufacturers Specialty Generic
Q1 2026
Published: Oct 10, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for CSUI

Reported

Report Date

Oct 10, 2025

Quarter Q1 2026

Revenue

N/A

YoY: N/A

EPS

0.00

YoY: +100.9%

Market Move

+5.00%

Previous quarter: Q3 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • EPS of $0.00 increased by 100.9% from previous year
  • Net income of 13.91K
  • "N/A" - N/A
CSUI
Company CSUI

Executive Summary

Cannabis Suisse Corp (CSUI) reported a challenging QQ1 2026, with material operating losses that overshadow a modest level of non-operating income. Net income of 13,907 (USD) was driven by 98,442 of total other income/expense, masking a -84,535 operating loss (before taxes). Gross profit stood at -1,061, as cost of revenue exceeded revenue in the quarter, signaling precarious unit economics absent a material revenue uptick. The combination of a heavily levered balance sheet, thin liquidity, and negative equity underscores a solvency and cash-flow risk profile despite a gaudy EBITDA figure of 31,265 that is largely a function of non-operating items.

Key Performance Indicators

Operating Income
Decreasing
-84.54K
QoQ: -28.62% | YoY: -2.15%
Net Income
Increasing
13.91K
QoQ: -52.88% | YoY: 101.29%
EPS
Increasing
0.00
QoQ: -50.00% | YoY: 100.88%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2026 0.00 0.00 +0.0% View
Q1 2026 0.00 0.00 +0.0% View
Q3 2025 0.01 0.00 +0.0% View
Q2 2025 0.01 0.00 +0.0% View
Q1 2025 0.01 -0.01 +0.0% View